The Impact of the enforcement of Guidelines for Prescription Drug Marketing Information Provision on information provision by pharmaceutical companies to medical institution

○Aya Toma

[30P-am341S] The Impact of the enforcement of Guidelines for Prescription Drug Marketing Information Provision on information provision by pharmaceutical companies to medical institution

○Aya Toma¹, Shinichi Watanabe², Shingo Kondo^1,3, Hiroki Iwata^1,3, Noriko Kobayashi^1,3, Katsunori Yamaura^1,3 (1. Keio Univ Faculty Pharm, 2. Teikyo Heisei Univ Faculty Pharm, 3. Keio Univ Commun Pharm)

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Presentation information

[30P-am] Social Pharmacy

[30P-am341S] The Impact of the enforcement of Guidelines for Prescription Drug Marketing Information Provision on information provision by pharmaceutical companies to medical institution

Password